ArticleTranslational lung cancer research2024

Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective study.

Jingyuan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.